The earnings call highlighted significant growth in Galleri revenue, improvements in cost efficiency, and strategic partnerships, while also noting a substantial net loss for the full year and a decrease in development services revenue. The company is focused on reducing cash burn and has a strong cash position. Overall, the positive aspects outweigh the negatives.

Company Guidance

During the GRAIL Fourth Quarter 2024 Earnings Call, the company provided guidance on various financial metrics and strategic initiatives. The call highlighted a significant restructure intended to extend the capital runway into 2028, with a focus on achieving key milestones such as the completion of the modular PMA submission for FDA approval of the Galleri test. GRAIL reported a 45% year-over-year growth in U.S. Galleri revenue, with over 137,000 tests sold, contributing to a total revenue of $38.3 million for Q4, up 26% from the previous year. The company's non-GAAP adjusted gross profit for the fourth quarter increased by 17% to $17.9 million, while the adjusted EBITDA improved by 32% to negative $84 million. For the full year, GRAIL's revenue reached $125.6 million, marking a 35% increase from 2023, with a screening revenue of $108.6 million, up 45% year-over-year. The call also emphasized the rollout of an enhanced version of Galleri to support testing at scale and the addition of the Galleri test to TRICARE's approved lab-developed tests list. GRAIL's cash burn for 2025 is projected to decrease by over 40%, aiming for no more than $320 million, with a strong cash position of $766.8 million at the end of 2024.

U.S. Galleri Revenue Growth

U.S. Galleri revenue grew by 45% year-over-year, with more than 137,000 Galleri tests sold.

Financial Performance

Fourth quarter revenue was $38.3 million, up 26% from Q4 2023. Full-year revenue was $125.6 million, up 35% from 2023.

Cost Efficiency Improvements

The company implemented a new version of the Galleri test, reducing sequencing costs and automating testing workflows, leading to expanded lab capacity.

Partnerships and Coverage

Integration with Quest Diagnostics allows easier test ordering, and TRICARE added Galleri to its list of approved lab-developed tests for certain patients.

Net Loss Improvement

Net loss for the fourth quarter improved by 48% compared to Q4 2023.

Cash Burn Reduction

Projected cash burn for 2025 is expected to decrease by more than 40% compared to 2024.

---

GRAIL Inc (GRAL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

GRAL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 19, 2025	2025 (Q2)	- / -	-51.05	―	―	―
Feb 20, 2025	2024 (Q4)	-4.97 / -2.89	-6.039	52.14% (+3.15)	―
Nov 12, 2024	2024 (Q3)	-6.43 / -3.94	―	―	―
Aug 13, 2024	2024 (Q2)	- / -51.05	-6.217	-721.22% (-44.84)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

GRAL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Feb 20, 2025	$47.76	―	―
Nov 12, 2024	$15.09	$15.92	+5.50%
Aug 13, 2024	$15.84	$15.39	-2.84%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---

FAQ

When does GRAIL Inc (GRAL) report earnings?

GRAIL Inc (GRAL) is schdueled to report earning on Aug 19, 2025, TBA Not Confirmed.

What is GRAIL Inc (GRAL) earnings time?

GRAIL Inc (GRAL) earnings time is at Aug 19, 2025, TBA Not Confirmed.

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is GRAL EPS forecast?

GRAL EPS forecast for the fiscal quarter 2025 (Q2) is -4.97.

---

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing